Sanofi Hit With $20M Suit Over Osteoarthritis Cream

Law360, Los Angeles (March 17, 2014, 6:08 PM EDT) -- Elorac Inc. hit Sanofi-Aventis Canada Inc. with a $20 million breach of contract lawsuit in Illinois federal court on Monday, accusing Sanofi of failing to successfully commercialize a Civamide topical cream used to treat osteoarthritis, despite an obligation to do so in good faith.

According to the suit, Sanofi agreed to use reasonable efforts to develop, market, promote and sell the Civamide cream in accordance with a license agreement. Sanofi instead, in bad faith, has chosen to do nothing to market the product and instead pass...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Elorac, Inc. v. Sanofi-Aventis Canada Inc.


Case Number

1:14-cv-01859

Court

Illinois Northern

Nature of Suit

190(Contract: Other)

Judge

Honorable Jorge L. Alonso

Date Filed

March 17, 2014

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.